DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Arai T, Sasaki D, Araya T, Sato T, Sohma Y, Kanai M.
A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers.
ChemBioChem 2014;
15 (17) 2577-2583
We do not assume any responsibility for the contents of the web pages of other providers.